IRIS Accounts Production v23.3.0.418 12288279 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false 385 16 600 1140 3052 739 2067 385 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122882792022-03-31122882792023-03-31122882792022-04-012023-03-31122882792021-03-31122882792021-04-012022-03-31122882792022-03-3112288279ns10:Originalns15:EnglandWales2022-04-012023-03-3112288279ns14:PoundSterlingns10:Original2022-04-012023-03-3112288279ns10:Originalns10:Director12022-04-012023-03-3112288279ns10:Original2022-04-012023-03-3112288279ns10:Original2023-03-3112288279ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3112288279ns10:Originalns10:Micro-entities2022-04-012023-03-3112288279ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3112288279ns10:Originalns10:FullAccounts2022-04-012023-03-3112288279ns10:Original42ns10:Director22022-03-3112288279ns10:Original42ns10:Director22021-03-3112288279ns10:Original42ns10:Director22022-04-012023-03-3112288279ns10:Original42ns10:Director22021-04-012022-03-3112288279ns10:Original42ns10:Director22023-03-3112288279ns10:Original42ns10:Director22022-03-3112288279ns10:Original2022-03-3112288279ns10:Originalns5:CurrentFinancialInstruments2023-03-3112288279ns10:Originalns5:CurrentFinancialInstruments2022-03-3112288279ns10:Originalns10:RegisteredOffice2022-04-012023-03-3112288279ns10:Original2021-04-012022-03-3112288279ns10:Originalns10:Director22022-04-012023-03-3112288279ns10:Original1ns10:Director12022-03-3112288279ns10:Original1ns10:Director12021-03-3112288279ns10:Original1ns10:Director12022-04-012023-03-3112288279ns10:Original1ns10:Director12021-04-012022-03-3112288279ns10:Original1ns10:Director12023-03-3112288279ns10:Original1ns10:Director12022-03-31
REGISTERED NUMBER: 12288279 (England and Wales)









Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Xypnotic Lab Limited

Xypnotic Lab Limited (Registered number: 12288279)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Balance Sheet 1


Xypnotic Lab Limited (Registered number: 12288279)

Balance Sheet
31 March 2023

31.3.23 31.3.22
£ £
FIXED ASSETS 1,364 827

CURRENT ASSETS 11,527 2,986

CREDITORS
Amounts falling due within one year (12,664 ) (3,649 )
NET CURRENT LIABILITIES (1,137 ) (663 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

227

164

CAPITAL AND RESERVES 227 164

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Xypnotic Lab Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12288279

Registered office: Unit 7
Mulberry Place
Pinnell Road
Eltham
London
SE9 6AR

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

31.3.23 31.3.22
£ £
Dr I Darok and Mrs I Darok
Balance outstanding at start of year 385 (16 )
Amounts advanced 600 1,140
Amounts repaid (3,052 ) (739 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (2,067 ) 385

The above loan is interest free and repayable upon demand.



Xypnotic Lab Limited (Registered number: 12288279)

Balance Sheet - continued
31 March 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 November 2023 and were signed on its behalf by:





Dr I Darok - Director